Showing 9,381 - 9,400 results of 24,146 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 0.73s Refine Results
  1. 9381
  2. 9382
  3. 9383
  4. 9384
  5. 9385

    Barbie audit data. by Cylie Williams (3446018)

    Published 2025
    “…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
  6. 9386

    The FEET system of barbie categorisation. by Cylie Williams (3446018)

    Published 2025
    “…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
  7. 9387

    Table_1_Vegetation vs. Anoxic Controls on Degradation of Plant Litter in a Restored Wetland.XLSX by Peter J. Hernes (8640351)

    Published 2020
    “…However, in an experiment initiated soon after the restored wetlands were constructed, Λ<sub>8</sub> in tule litter decreased from 6.8 to 3.6 mg 100 mgOC<sup>–1</sup>, highlighting the prevalence of initial oxic conditions. …”
  8. 9388

    In vitro fermentation characteristics of ruminant diets using ethanol extract of brown propolis as a nutritional additive by Maria de Fátima Falcão Gomes (12802294)

    Published 2022
    “…Dry matter degradability of diet decreased exponentially as a function of the increase in dose (y = 678.55×dose–0.271). …”
  9. 9389

    Effect of ibuprofen (IBU) on carbonic anhydrase IX (CA IX) expression. by Katarina Grossmannova (7543517)

    Published 2025
    “…(A) Detection of CA IX protein by Western blot showed that IBU downregulated CA IX protein levels in a time- and dose-dependent manner. …”
  10. 9390
  11. 9391
  12. 9392

    Summary of sequence data. by Yao Li (154923)

    Published 2023
    “…Spraying Pro-Ca under salt stress significantly increased in ascorbate peroxidase, superoxide dismutase, and peroxidase activity by 84.2%, 75.2%, and 3.5% as compared to the salt treatment, as demonstrated by an example of a 24-hour treatment. Malondialdehyde level in Pro-Ca was also dramatically decreased by 5.8%. …”
  13. 9393

    Behavioral, cognitive, and biological alterations in <i>Trypanosoma cruzi</i>-infected mice. by Glaucia Vilar-Pereira (686134)

    Published 2024
    “…<p>(<b>A</b>) Heatmap corresponding to behavioral and cognitive traits in non-infected control mice (NI) and infected with 100 bt forms of the Colombian Type I strain (<i>T</i>. …”
  14. 9394

    Supplementary Material for: Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilizatio... by Teich N. (9871244)

    Published 2020
    “…<b><i>Results:</i></b> Two hundred and ninety-four patients were included in the study. We observed a statistically significant reduction in the number of CD-related hospitalizations from the year before baseline (mean 1.00 per patient, SD ± 0.93) to the mean value of the 1st (0.62, SD ± 0.95) and 2nd year (0.32, SD ± 0.75) of the observation period (<i>p</i> < 0.0001). …”
  15. 9395

    S3 File - by Jens Panse (350046)

    Published 2024
    “…</p><p>Trial registration</p><p><b>Trial registration numbers:</b> PADDOCK (<a href="https://clinicaltrials.gov/ct2/show/NCT02588833" target="_blank">NCT02588833</a>), PRINCE (<a href="https://clinicaltrials.gov/ct2/show/NCT04085601" target="_blank">NCT04085601</a>; EudraCT, 2018-004220-11), PEGASUS (<a href="https://clinicaltrials.gov/ct2/show/NCT03500549" target="_blank">NCT03500549</a>).…”
  16. 9396

    S2 File - by Jens Panse (350046)

    Published 2024
    “…</p><p>Trial registration</p><p><b>Trial registration numbers:</b> PADDOCK (<a href="https://clinicaltrials.gov/ct2/show/NCT02588833" target="_blank">NCT02588833</a>), PRINCE (<a href="https://clinicaltrials.gov/ct2/show/NCT04085601" target="_blank">NCT04085601</a>; EudraCT, 2018-004220-11), PEGASUS (<a href="https://clinicaltrials.gov/ct2/show/NCT03500549" target="_blank">NCT03500549</a>).…”
  17. 9397

    Overview of the post hoc analysis. by Jens Panse (350046)

    Published 2024
    “…</p><p>Trial registration</p><p><b>Trial registration numbers:</b> PADDOCK (<a href="https://clinicaltrials.gov/ct2/show/NCT02588833" target="_blank">NCT02588833</a>), PRINCE (<a href="https://clinicaltrials.gov/ct2/show/NCT04085601" target="_blank">NCT04085601</a>; EudraCT, 2018-004220-11), PEGASUS (<a href="https://clinicaltrials.gov/ct2/show/NCT03500549" target="_blank">NCT03500549</a>).…”
  18. 9398

    S1 File - by Jens Panse (350046)

    Published 2024
    “…</p><p>Trial registration</p><p><b>Trial registration numbers:</b> PADDOCK (<a href="https://clinicaltrials.gov/ct2/show/NCT02588833" target="_blank">NCT02588833</a>), PRINCE (<a href="https://clinicaltrials.gov/ct2/show/NCT04085601" target="_blank">NCT04085601</a>; EudraCT, 2018-004220-11), PEGASUS (<a href="https://clinicaltrials.gov/ct2/show/NCT03500549" target="_blank">NCT03500549</a>).…”
  19. 9399
  20. 9400